VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 16 filers reported holding VIRPAX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $80,700 | -25.9% | 100,875 | 0.0% | 0.00% | – |
Q2 2023 | $108,945 | +37.6% | 100,875 | 0.0% | 0.00% | – |
Q1 2023 | $79,187 | +26.2% | 100,875 | 0.0% | 0.00% | – |
Q4 2022 | $62,744 | -47.7% | 100,875 | 0.0% | 0.00% | – |
Q3 2022 | $120,000 | -29.0% | 100,875 | 0.0% | 0.00% | – |
Q2 2022 | $169,000 | +201.8% | 100,875 | +301.5% | 0.00% | – |
Q1 2022 | $56,000 | -34.9% | 25,125 | 0.0% | 0.00% | – |
Q4 2021 | $86,000 | – | 25,125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,059,383 | $1,780,000 | 1.21% |
Quantum Private Wealth, LLC | 10,000 | $16,000 | 0.01% |
Warberg Asset Management LLC | 19,500 | $33,000 | 0.01% |
OSAIC HOLDINGS, INC. | 160 | $0 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 100,875 | $169,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 57 | $0 | 0.00% |
NORTHERN TRUST CORP | 15,221 | $26,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 66,223 | $111,000 | 0.00% |
MORGAN STANLEY | 18,016 | $30,000 | 0.00% |